U.S. Markets close in 1 hr 41 mins

What Are Accelerate Diagnostics’ Key Strengths?

Kenneth Smith
What Are Accelerate Diagnostics’ Key Strengths?

How Is Accelerate Diagnostics Positioned at the Start of 2018? In June 2017, Accelerate Diagnostics (AXDX) raised net proceeds of $83.2 million from a public offering of 2.8 million shares of common stock. As a result of the offering, the cash position of the company increased to $121.3 million at the end of 3Q17 as compared with $77.8 million at the end of 3Q16.